NASDAQ:PASG | Free Cash Flow | Passage BIO, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2019-03-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$12.99M
2025-12-31-$6.48M
2025-03-31-$13.85M
2024-12-31-$8.44M
2024-03-31-$18.93M
2023-12-31-$19.52M
2023-03-31-$22.45M
2022-12-31-$24.02M
2022-03-31-$44.71M
2021-12-31-$30.78M
2021-03-31-$30.72M
2020-12-31-$29.42M
2020-03-31-$21.85M
2019-12-31-$17.48M
2019-03-31-$214,000.00

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$31.51M
2024-12-31-$47.96M
2023-12-31-$78.26M
2022-12-31-$118.21M
2021-12-31-$126.88M
2020-12-31-$80.52M
2019-12-31-$39.9M